These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10828026)

  • 1. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.
    Moreau A; Lacroix-Desmazes S; Stieltjes N; Saenko E; Kaveri SV; D'Oiron R; Sultan Y; Scandella D; Kazatchkine MD
    Blood; 2000 Jun; 95(11):3435-41. PubMed ID: 10828026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M; Branckaert T; Laub R
    Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to factor VIII with catalytic activity.
    Bayry J; Lacroix-Desmazes S; Pashov A; Stahl D; Hoebeke J; Kazatchkine MD; Kaveri SV
    Autoimmun Rev; 2003 Jan; 2(1):30-5. PubMed ID: 12848973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
    J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals.
    Algiman M; Dietrich G; Nydegger UE; Boieldieu D; Sultan Y; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3795-9. PubMed ID: 1570298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of human anti-factor VIII antibodies for functional polystyrene supports.
    Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.
    Fulcher CA; de Graaf Mahoney S; Roberts JR; Kasper CK; Zimmerman TS
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7728-32. PubMed ID: 2415970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A.
    Peerlinck K; Jacquemin MG; Arnout J; Hoylaerts MF; Gilles JG; Lavend'homme R; Johnson KM; Freson K; Scandella D; Saint-Remy JM; Vermylen J
    Blood; 1999 Apr; 93(7):2267-73. PubMed ID: 10090936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.
    Fulcher CA; de Graaf Mahoney S; Zimmerman TS
    Blood; 1987 May; 69(5):1475-80. PubMed ID: 2436689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.